Upcoming Ask the Expert Webinar – The Asp-PSC Trial: What Patients Need to Know
Register for our first live Ask the Expert of 2026, taking place on Monday 2nd March at 7pm (UK).
World CCA Day: Tackling Cholangiocarcinoma
How is PSC Support tackling bile duct cancer? Discover the research we’re funding to improve early detection and treatment for cholangiocarcinoma (CCA).
Progress and Plans at the ERN RARE-LIVER Members’ Meeting 2026
Martine Walmsley shares project updates and future goals from the 2026 Prague members’ meeting.
Improving Liver Care for People with PSC
Medway NHS Foundation Trust becomes the 20th UK service to achieve IQILS accreditation.
Epstein-Barr Virus and PSC
New research explores a potential link between Epstein-Barr virus and primary sclerosing cholangitis.
Major Milestone Reached in PSC Cancer Risk Study
100 samples collected: DNA methylation study advances early cancer detection in PSC.
January 2026 Research Roundup
PSC Support recently attended the British Association for the Study of the Liver (BASL) Immune Special Interest Group (SIG) meeting. This meeting highlighted important progress in research and care, and on new medications for autoimmune liver diseases.
Progress Update: Characterising Genetic Changes in Bile Ducts
PSC research on genetic changes in bile ducts is now in its key analytical phase to unlock understanding.
Molecular Signatures Identified to Predict Primary Sclerosing Cholangitis Progression and Cancer Risk
New blood-based markers could help predict primary sclerosing cholangitis progression and cancer risk.